Sanofi acquires Kymab in $1.5B deal

Note: This section contains information in English only.
Source: Dukascopy Bank SA
French drugmaker Sanofi agreed to acquire Kymab, the British immunotherapy company, in a deal worth up to $1.45B, seeking to expand in a rapid-growing medical area.
Back to articles

Actual Topics

Mon, 11 Jan 2021 13:24:04 GMT

China wants tech titans to share customer loan data

Chinese regulators are set to push tech giants, such as JD.com. Tencent and Ant Group, to share consumer credit data in order to prevent fraud and excessive borrowing amid Beijing's latest scrutiny.

Mon, 11 Jan 2021 10:42:57 GMT

Smartphone sales fall in China

On Monday, Chinese government data revealed that smartphone shipments in 2020 had fallen by 20.4%, compared to the prior year.

Subscribe to "Fundamental Analysis" feed

Souscrire
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.